291 related articles for article (PubMed ID: 28186535)
1. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group.
Maggiore U; Budde K; Heemann U; Hilbrands L; Oberbauer R; Oniscu GC; Pascual J; Schwartz Sorensen S; Viklicky O; Abramowicz D;
Nephrol Dial Transplant; 2017 Feb; 32(2):216-223. PubMed ID: 28186535
[TBL] [Abstract][Full Text] [Related]
2. Moving closer to understanding the risks of living kidney donation.
Steiner RW
Clin Transplant; 2016 Jan; 30(1):10-6. PubMed ID: 26689427
[TBL] [Abstract][Full Text] [Related]
3. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
4. End-stage renal disease after kidney donation: a single-center experience.
Rosenblatt GS; Nakamura N; Barry JM
Transplant Proc; 2008 Jun; 40(5):1315-8. PubMed ID: 18589095
[TBL] [Abstract][Full Text] [Related]
5. Long-term Mortality Risks Among Living Kidney Donors in Korea.
Kim Y; Yu MY; Yoo KD; Jeong CW; Kim HH; Min SI; Ha J; Choi Y; Ko AR; Yun JM; Park SM; Yang SH; Kim DK; Oh KH; Joo KW; Ahn C; Kim YS; Lee H
Am J Kidney Dis; 2020 Jun; 75(6):919-925. PubMed ID: 31866225
[TBL] [Abstract][Full Text] [Related]
6. Increasing Use of the Expanded Criteria for Living Kidney Donation and Good Outcomes of Living Kidney Donors in Korea.
Lim HJ; Jambaldorj E; Lee Y; Kang SS; Koo TY; Ahn C; Yang J
Transplant Proc; 2016 Sep; 48(7):2407-2411. PubMed ID: 27742310
[TBL] [Abstract][Full Text] [Related]
7. Causes and timing of end-stage renal disease after living kidney donation.
Matas AJ; Berglund DM; Vock DM; Ibrahim HN
Am J Transplant; 2018 May; 18(5):1140-1150. PubMed ID: 29369517
[TBL] [Abstract][Full Text] [Related]
8. End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?
Lam NN; Lentine KL; Garg AX
Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):592-6. PubMed ID: 25160076
[TBL] [Abstract][Full Text] [Related]
9. Potential risks of living kidney donation--a review.
Gai M; Giunti S; Lanfranco G; Segoloni GP
Nephrol Dial Transplant; 2007 Nov; 22(11):3122-7. PubMed ID: 17640938
[No Abstract] [Full Text] [Related]
10. The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.
Vock DM; Helgeson ES; Mullan AF; Issa NS; Sanka S; Saiki AC; Mathson K; Chamberlain AM; Rule AD; Matas AJ
BMC Nephrol; 2023 May; 24(1):121. PubMed ID: 37127560
[TBL] [Abstract][Full Text] [Related]
11. Does Low Birthweight Have an Impact on Living Kidney Donor Outcomes?
Jędrzejko K; Kieszek R; Dor FJMF; Kwapisz M; Nita M; Bieniasz M; Czerwińska M; Kwiatkowski A
Transplant Proc; 2018; 50(6):1710-1714. PubMed ID: 30056887
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Non-End-Stage Renal Disease Risks After Living Kidney Donation.
Matas AJ; Hays RE; Ibrahim HN
Am J Transplant; 2017 Apr; 17(4):893-900. PubMed ID: 27529688
[TBL] [Abstract][Full Text] [Related]
13. What is the significance of end-stage renal disease risk estimation in living kidney donors?
Gaillard F; Baron S; Timsit MO; Eladari D; Fournier C; Prot-Bertoye C; Bertocchio JP; Lamhaut L; Friedlander G; Méjean A; Legendre C; Courbebaisse M
Transpl Int; 2017 Aug; 30(8):799-806. PubMed ID: 28152216
[TBL] [Abstract][Full Text] [Related]
14. Estimating risks of de novo kidney diseases after living kidney donation.
Steiner RW; Ix JH; Rifkin DE; Gert B
Am J Transplant; 2014 Mar; 14(3):538-44. PubMed ID: 24612746
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of living kidney donors: a single centre experience of 29 years.
Chu KH; Poon CK; Lam CM; Cheuk A; Yim KF; Lee W; Tang HL; Chan HW; Fung KS; Tong KL
Nephrology (Carlton); 2012 Jan; 17(1):85-8. PubMed ID: 21919999
[TBL] [Abstract][Full Text] [Related]
16. Lifetime risks of kidney donation: a medical decision analysis.
Kiberd BA; Tennankore KK
BMJ Open; 2017 Sep; 7(8):e016490. PubMed ID: 28864484
[TBL] [Abstract][Full Text] [Related]
17. Long-term medical risks to the living kidney donor.
Lam NN; Lentine KL; Levey AS; Kasiske BL; Garg AX
Nat Rev Nephrol; 2015 Jul; 11(7):411-9. PubMed ID: 25941060
[TBL] [Abstract][Full Text] [Related]
18. Impact of the individualized risks of end-stage renal disease on living kidney donor selection.
Nguyen QL; Merville P; Couzi L
Nephrol Dial Transplant; 2018 Dec; 33(12):2245-2252. PubMed ID: 29846692
[TBL] [Abstract][Full Text] [Related]
19. Patient Perspectives on Weight Management for Living Kidney Donation.
Mustian MN; Hanaway M; Kumar V; Reed RD; Shelton BA; Grant R; Carter A; Locke JE
J Surg Res; 2019 Dec; 244():50-56. PubMed ID: 31279263
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of living kidney donors: a longitudinal study.
El-Agroudy AE; Sabry AA; Wafa EW; Neamatalla AH; Ismail AM; Mohsen T; Khalil AA; Shokeir AA; Ghoneim MA
BJU Int; 2007 Dec; 100(6):1351-5. PubMed ID: 17941927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
